Vera Therapeutics, Inc. (VERA)

42.33 -2.61 (-5.81%) 收市：04:00PM EDT

Vera Therapeutics, Inc.

8000 Marina Boulevard
Suite 120
Brisbane, CA 94005
United States
650 770 0077
https://veratx.com

版塊: Healthcare
行業: Biotechnology
全職員工: 51

高階主管

名稱	頭銜	支付	行使價	出生年份
Dr. Marshall W. Fordyce M.D.	Founder, President, CEO & Director	910.14k	無	1975
Mr. Sean P. Grant M.B.A.	Chief Financial Officer	642k	無	1985
Mr. Joseph R. Young M.B.A.	Senior VP of Finance & Chief Accounting Officer	無	無	1973
Mr. Julien E. Capers J.D.	VP & Head of Legal	無	無	無
Ms. Kelly Rauber	VP & Head of Human Resources	無	無	無
Mr. Tom Doan	Senior Vice President of Development Operations	無	無	1972
Ms. Lauren Frenz	Chief Business Officer	無	無	1985
Dr. Neeraj Pakala M.B.A., Ph.D.	Senior VP and Head of Product Development & Manufacturing	無	無	無
Dr. Kerry Cooper M.D.	Senior Vice President of Medical Affairs	無	無	無
Dr. Robert M. Brenner M.D.	Chief Medical Officer	無	無	1968

截止 2023年12月31日為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 USD。

描述

Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase III clinical trial for patients with immunoglobulin A nephropathy; and for treatment of lupus nephritis that is in Phase II clinical trial. It is also developing MAU868, a human monoclonal antibody for the treatment of BK viremia infections. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in Brisbane, California.

公司管治

截至 2024年5月1日 止，Vera Therapeutics, Inc. 的 ISS 管治質素評分為 7。 Pillar 分數正在審核中：6；董事會：6；股東權利：8；現金賠償：8。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。